Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.

IF 12.9 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Hepatology Pub Date : 2024-05-22 DOI:10.1097/HEP.0000000000000933
Mary P Moore, Xiaobo Wang, John Paul Kennelly, Hongxue Shi, Yuki Ishino, Kuniyuki Kano, Junken Aoki, Alessandro Cherubini, Luisa Ronzoni, Xiuqing Guo, Naga P Chalasani, Shareef Khalid, Danish Saleheen, Matthew A Mitsche, Jerome I Rotter, Katherine P Yates, Luca Valenti, Nozomu Kono, Peter Tontonoz, Ira Tabas
{"title":"Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.","authors":"Mary P Moore, Xiaobo Wang, John Paul Kennelly, Hongxue Shi, Yuki Ishino, Kuniyuki Kano, Junken Aoki, Alessandro Cherubini, Luisa Ronzoni, Xiuqing Guo, Naga P Chalasani, Shareef Khalid, Danish Saleheen, Matthew A Mitsche, Jerome I Rotter, Katherine P Yates, Luca Valenti, Nozomu Kono, Peter Tontonoz, Ira Tabas","doi":"10.1097/HEP.0000000000000933","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>The common genetic variant rs641738 C>T is a risk factor for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASH), including liver fibrosis, and is associated with decreased expression of the phospholipid-remodeling enzyme MBOAT7 (LPIAT1). However, whether restoring MBOAT7 expression in established metabolic dysfunction-associated steatotic liver disease dampens the progression to liver fibrosis and, importantly, the mechanism through which decreased MBOAT7 expression exacerbates MASH fibrosis remain unclear.</p><p><strong>Approach and results: </strong>We first showed that hepatocyte MBOAT7 restoration in mice with diet-induced steatohepatitis slows the progression to liver fibrosis. Conversely, when hepatocyte-MBOAT7 was silenced in mice with established hepatosteatosis, liver fibrosis but not hepatosteatosis was exacerbated. Mechanistic studies revealed that hepatocyte-MBOAT7 restoration in MASH mice lowered hepatocyte-TAZ (WWTR1), which is known to promote MASH fibrosis. Conversely, hepatocyte-MBOAT7 silencing enhanced TAZ upregulation in MASH. Finally, we discovered that changes in hepatocyte phospholipids due to MBOAT7 loss-of-function promote a cholesterol trafficking pathway that upregulates TAZ and the TAZ-induced profibrotic factor Indian hedgehog (IHH). As evidence for relevance in humans, we found that the livers of individuals with MASH carrying the rs641738-T allele had higher hepatocyte nuclear TAZ, indicating higher TAZ activity and increased IHH mRNA.</p><p><strong>Conclusions: </strong>This study provides evidence for a novel mechanism linking MBOAT7-LoF to MASH fibrosis, adds new insight into an established genetic locus for MASH, and, given the druggability of hepatocyte TAZ for MASH fibrosis, suggests a personalized medicine approach for subjects at increased risk for MASH fibrosis due to inheritance of variants that lower MBOAT7.</p>","PeriodicalId":177,"journal":{"name":"Hepatology","volume":null,"pages":null},"PeriodicalIF":12.9000,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HEP.0000000000000933","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: The common genetic variant rs641738 C>T is a risk factor for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASH), including liver fibrosis, and is associated with decreased expression of the phospholipid-remodeling enzyme MBOAT7 (LPIAT1). However, whether restoring MBOAT7 expression in established metabolic dysfunction-associated steatotic liver disease dampens the progression to liver fibrosis and, importantly, the mechanism through which decreased MBOAT7 expression exacerbates MASH fibrosis remain unclear.

Approach and results: We first showed that hepatocyte MBOAT7 restoration in mice with diet-induced steatohepatitis slows the progression to liver fibrosis. Conversely, when hepatocyte-MBOAT7 was silenced in mice with established hepatosteatosis, liver fibrosis but not hepatosteatosis was exacerbated. Mechanistic studies revealed that hepatocyte-MBOAT7 restoration in MASH mice lowered hepatocyte-TAZ (WWTR1), which is known to promote MASH fibrosis. Conversely, hepatocyte-MBOAT7 silencing enhanced TAZ upregulation in MASH. Finally, we discovered that changes in hepatocyte phospholipids due to MBOAT7 loss-of-function promote a cholesterol trafficking pathway that upregulates TAZ and the TAZ-induced profibrotic factor Indian hedgehog (IHH). As evidence for relevance in humans, we found that the livers of individuals with MASH carrying the rs641738-T allele had higher hepatocyte nuclear TAZ, indicating higher TAZ activity and increased IHH mRNA.

Conclusions: This study provides evidence for a novel mechanism linking MBOAT7-LoF to MASH fibrosis, adds new insight into an established genetic locus for MASH, and, given the druggability of hepatocyte TAZ for MASH fibrosis, suggests a personalized medicine approach for subjects at increased risk for MASH fibrosis due to inheritance of variants that lower MBOAT7.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低 MBOAT7 表达是 MASH 的遗传风险之一,它促进了肝细胞 TAZ 上调的促纤维化途径。
背景和目的:常见的遗传变异rs641738 C>T是代谢功能障碍相关性脂肪性肝病(MASLD)和代谢功能障碍相关性脂肪性肝炎(MASH)(包括肝纤维化)的危险因素,与磷脂重塑酶MBOAT7(LPIAT1)的表达降低有关。然而,在已确诊的MASLD中恢复MBOAT7的表达是否会抑制肝纤维化的进展,以及重要的是,MBOAT7表达减少加剧MASH纤维化的机制仍不清楚:我们首先发现,饮食诱导的脂肪性肝炎小鼠肝细胞 MBOAT7 的恢复会减缓肝纤维化的进展。相反,如果在已形成肝脂肪变性的小鼠中沉默肝细胞-MBOAT7,则会加剧肝纤维化,但不会加剧肝脂肪变性。机理研究发现,MASH 小鼠肝细胞-MBOAT7 的恢复会降低肝细胞-TAZ(WWTR1),而众所周知,WWTR1 会促进 MASH 的肝纤维化。相反,沉默肝细胞-MBOAT7 会增强 MASH 中 TAZ 的上调。最后,我们发现由于 MBOAT7 功能缺失导致的肝细胞磷脂变化促进了胆固醇贩运途径,而胆固醇贩运途径可上调 TAZ 和 TAZ 诱导的促组织坏死因子印度刺猬(IHH)。作为与人类相关的证据,我们发现携带 rs641738-T 等位基因的 MASH 患者的肝脏具有较高的肝细胞核 TAZ,表明 TAZ 活性较高,且 IHH mRNA 增加:本研究为 MBOAT7-LoF 与 MASH 纤维化之间的新型关联机制提供了证据;为 MASH 的一个既定遗传位点增添了新的见解;鉴于肝细胞 TAZ 对 MASH 纤维化的可药性,本研究为因遗传 MBOAT7 较低的变体而导致 MASH 纤维化风险增加的受试者提出了一种个性化医疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hepatology
Hepatology 医学-胃肠肝病学
CiteScore
27.50
自引率
3.70%
发文量
609
审稿时长
1 months
期刊介绍: HEPATOLOGY is recognized as the leading publication in the field of liver disease. It features original, peer-reviewed articles covering various aspects of liver structure, function, and disease. The journal's distinguished Editorial Board carefully selects the best articles each month, focusing on topics including immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases, liver cancer, and drug metabolism.
期刊最新文献
Prevalence of hepatitis C virus hypervariable region 1 insertions and their role in antibody evasion Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4 Drug treatments to prevent first decompensation in cirrhosis New ubiquitomic subtypes in hepatocellular carcinoma: Insights for future therapeutic approaches Role of microbiome in autoimmune liver diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1